Camp Lejeune cancer lawsuit

Marines That Have Suffered From Kidney Cancer Can Sue The Federal Government

Many are angered the Marines failed to warn them or their family members that the local drinking water could cause cancer

Wednesday, August 31, 2022 - Camp Lejeune water lawsuits against the US federal government seek substantial lump-sum monetary compensation. US Marines have been injured or died from cancer allegedly from drinking the tap water available throughout the marine base. Those who served at Camp Lejeune, North Carolina marine base for at least 30-days from 1953 to 1987 were exposed to volatile organic compounds trichloroethylene (TCE), tetrachloroethylene (PCE), 1,2-dichloroethylene (DCE), and vinyl chloride, and benzene. Marines have suffered through many decades from a long list of cancer that could have been avoided had the US military been forthcoming with information they had about two main water treatment facilities testing positive for the above-mentioned carcinogenic chemicals.

Kidney cancer is on the list of presumptive illnesses the Veterans Administration (VA) confirms was caused by drinking Camp Lejeune water. The MayoClinic lists, "blood in your urine, which may appear pink, red or cola-colored, pain in your back or side that doesn't go away, loss of appetite, unexplained weight loss, tiredness, and fever," as signals that one may have kidney cancer. Early diagnosis and treatment of kidney cancer are essential with kidney cancer, as with all types of cancer, to effectively treat the disease. Of all types of Camp Lejeune cancer, cancer of the kidneys may be the most survivable. Cancer.net educates readers that kidney cancer is usually caught early enough to be treated about two-thirds of the time producing a survival rate of more than 90%. The rate of kidney cancer survival decreases if the disease spreads to nearby tissue or other organs, which makes it more difficult to treat except with chemotherapy. Doctors first assess the size of the kidney cancer tumor to see if other organs have been compromised. Hopkins Medicine.org has found that most types of kidney cancer can be cured with surgery to remove the entire tumor. In extreme cases, the entire kidney can be removed by conventional open incision surgery or by minimally invasive laparoscopic surgery. Open surgery is more painful and requires a longer recovery time. Pain medicine is usually prescribed. The recovery time from open kidney removal surgery can be longer than 8 weeks although the patient usually remains in the hospital for about one week. Kidney cancer sometimes reoccurs if only the tumor is excised according to the CancerCouncil. Most forms of kidney cancer surgery are safe but carry all of the risks of any open incision surgery like excessive bleeding and infection at the spot of the incision.

As mentioned before, most kidney cancer victims that lived or worked at Camp Lejeune could have been avoided had the military come forward and immediately shut down the two contaminated water treatment facilities. The Marine Corps and Navy knew that the water table was being contaminated by several sources. Identified as leaking contaminates were several unlined wasted disposal landfills, underground fuel storage tanks, and a local dry cleaning business that disposed of toxic dry cleaning solution by pouring it into the nearby storm drains. The Camp Lejeune Justice Act, recently enacted into law, allows veterans with kidney cancer and others to sue the government for reimbursement of medical expenses, lost wages, and pain and suffering.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.